CVS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CVS 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CVS

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. 

CEO
J. David Joyner
CEOJ. David Joyner
Employees
300,000
Employees300,000
Headquarters
Woonsocket, Rhode Island
HeadquartersWoonsocket, Rhode Island
Founded
1963
Founded1963
Employees
300,000
Employees300,000

CVS Key Statistics

Market cap
123.96B
Market cap123.96B
Price-Earnings ratio
42.66
Price-Earnings ratio42.66
Dividend yield
2.74%
Dividend yield2.74%
Average volume
10.00M
Average volume10.00M
High today
$97.50
High today$97.50
Low today
$96.83
Low today$96.83
Open price
$98.35
Open price$98.35
Volume
6.67K
Volume6.67K
52 Week high
$98.43
52 Week high$98.43
52 Week low
$58.35
52 Week low$58.35

Stock Snapshot

The current CVS(CVS) stock price is $97.00, with a market capitalization of 123.96B. The stock trades at a price-to-earnings (P/E) ratio of 42.66 and offers a dividend yield of 2.7%.

On 2026-05-15, CVS(CVS) stock moved within a range of $96.83 to $97.50. With shares now at $97.00, the stock is trading +0.2% above its intraday low and -0.5% below the session's peak.

Trading activity shows a volume of 6.67K, compared to an average daily volume of 10M.

The stock's 52-week range extends from a low of $58.35 to a high of $98.43.

The stock's 52-week range extends from a low of $58.35 to a high of $98.43.

CVS News

24/7 Wall St. 19h
Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge By Vandita Jadeja Published May 14, 1:00PM EDT Quick Read CVS Health (CVS) posted Q1 adjuste...

Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge
TipRanks 19h
CVS Health price target raised to $106 from $93 at Morgan Stanley

Morgan Stanley raised the firm’s price target on CVS Health (CVS) to $106 from $93 and keeps an Overweight rating on the shares. Unlock hedge fund-level data a...

Simply Wall St 1d
CVS Health Reshapes Portfolio With Omnicare Exit Drones And Biosimilars Focus

CVS Health (NYSE:CVS) is divesting its Omnicare subsidiary to GenieRx, with the transaction approved by the U.S. Bankruptcy Court and awaiting regulatory approv...

CVS Health Reshapes Portfolio With Omnicare Exit Drones And Biosimilars Focus

Analyst ratings

83%

of 29 ratings
Buy
82.8%
Hold
17.2%
Sell
0%

More CVS News

TipRanks 2d
CVS Health granted court approval for sale of business to GenieRx

CVS Health (CVS) subsidiary Omnicare announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas has app...

Nasdaq 2d
Why CVS Stock Topped the Market on Tuesday

Key Points A pair of analysts raised their price targets on the pharmacy operator's shares. Both maintained their equivalents of buy recommendations. 10 stoc...

Why CVS Stock Topped the Market on Tuesday
Zacks 3d
CVS Health is a Top-Ranked Growth Stock: Should You Buy?

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...

CVS Health is a Top-Ranked Growth Stock: Should You Buy?
TipRanks 3d
Top CVS Health Executive Makes a Major Move With Multimillion-Dollar Stock Sale

New insider activity at CVS Health ( (CVS) ) has taken place on May 11, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...

TipRanks 4d
CVS Health price target raised to $110 from $105 at TD Cowen

TD Cowen analyst Charles Rhyee raised the firm’s price target on CVS Health (CVS) to $110 from $105 and keeps a Buy rating on the shares. The firm said they rem...

Benzinga 4d
Nvidia, CVS Health, Vertiv And An Energy Stock On CNBC's 'Final Trades'

According to recent news, Nvidia named Suzanne Nora Johnson to its board of directors on Friday. Jason Snipe, founder and chief investment officer of Odyssey C...

Nvidia, CVS Health, Vertiv And An Energy Stock On CNBC's 'Final Trades'
Simply Wall St 5d
Should CVS’s Strong Q1 2026 Results and Higher Outlook Require Action From CVS Health Investors?

CVS Health reported past first-quarter 2026 results with revenue of at least US$100.43 billion and net income of US$2.94 billion, alongside higher earnings guid...

Should CVS’s Strong Q1 2026 Results and Higher Outlook Require Action From CVS Health Investors?

People also own

Based on the portfolios of people who own CVS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.